Randomised, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Study of QGC001, a Centrally Acting Aminopeptidase A Inhibitor Prodrug

Fabrice Balavoine, Michel Azizi, Damien Bergerot et al. · Clinical Pharmacokinetics · 2013

Cited by 59 works. doi:10.1007/s40262-013-0125-y

Authors

References